Cargando...
Screening strategies for pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is rare and, if untreated, has a median survival of 2–3 years. Pulmonary arterial hypertension may be idiopathic (IPAH) but is frequently associated with other conditions. Despite increased awareness, therapeutic advances, and improved outcomes, the time from sy...
Guardado en:
| Publicado en: | Eur Heart J Suppl |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6915059/ https://ncbi.nlm.nih.gov/pubmed/31857796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suz204 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|